Randomized, double blind, placebo controlled, clinical trial to study co-administration of Ashwagandha on safety, immunogenicity, and protection with COVID-19 vaccine – A Study Protocol
View ORCID ProfileArvind Chopra, View ORCID ProfilePreeti Chavan-Gautam, View ORCID ProfileGirish Tillu, Manjit Saluja, View ORCID ProfileSwapnil Borse, View ORCID ProfileSanjeev Sarmukaddam, View ORCID ProfileSusmita Chaudhuri, View ORCID ProfileBCS Rao, Babita Yadav, Narayanam Srikanth, View ORCID ProfileBhushan Patwardhan
doi: https://doi.org/10.1101/2021.07.02.21259886
Arvind Chopra
1Centre for Rheumatic Diseases, Pune, India
Preeti Chavan-Gautam
2Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India
Girish Tillu
2Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India
Manjit Saluja
1Centre for Rheumatic Diseases, Pune, India
Swapnil Borse
2Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India
Sanjeev Sarmukaddam
Susmita Chaudhuri
3Translational Health Science and Technology Institute, Faridabad, India
BCS Rao
4Central Council for Research in Ayurvedic Sciences, New Delhi, India
Babita Yadav
4Central Council for Research in Ayurvedic Sciences, New Delhi, India
Narayanam Srikanth
4Central Council for Research in Ayurvedic Sciences, New Delhi, India
Bhushan Patwardhan
2Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India
Data Availability
The status of the study and the results (after final analysis) will be uploaded on CTRI Website URL - http://ctri.nic.in.
Posted July 06, 2021.
Randomized, double blind, placebo controlled, clinical trial to study co-administration of Ashwagandha on safety, immunogenicity, and protection with COVID-19 vaccine – A Study Protocol
Arvind Chopra, Preeti Chavan-Gautam, Girish Tillu, Manjit Saluja, Swapnil Borse, Sanjeev Sarmukaddam, Susmita Chaudhuri, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
medRxiv 2021.07.02.21259886; doi: https://doi.org/10.1101/2021.07.02.21259886
Randomized, double blind, placebo controlled, clinical trial to study co-administration of Ashwagandha on safety, immunogenicity, and protection with COVID-19 vaccine – A Study Protocol
Arvind Chopra, Preeti Chavan-Gautam, Girish Tillu, Manjit Saluja, Swapnil Borse, Sanjeev Sarmukaddam, Susmita Chaudhuri, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
medRxiv 2021.07.02.21259886; doi: https://doi.org/10.1101/2021.07.02.21259886
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12506)
- Forensic Medicine (10)
- Gastroenterology (797)
- Genetic and Genomic Medicine (4372)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2821)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (889)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4140)
- Nursing (219)
- Nutrition (614)
- Oncology (2178)
- Ophthalmology (618)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (261)
- Palliative Medicine (81)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6725)
- Radiology and Imaging (1477)
- Respiratory Medicine (893)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)